1. Vasu MA, O’Keefe DD. Kapellakis GZ, Vezeridis MP, Jacobs ML, Daggett WM, Powell WJ, Jr. Myocardial oxygen consumption: effects of epinephrine, isoproterenol, dopamine, norepinephrine and dobutamine. Am J Physiol 1978; 235: H237.
2. Ruffo RR. Review: The pharmacology of dobutamine. Am J Med Sci 1987; 294: 244.
3. Lang RM, David D, Neumann A, Weinert L, Borow KM. In vivo assessment of the independent effects of heart rate, contractility and systolic loading conditions on myocardial oxygen consumption. J Am Coll Cardiol 1989; 13 (Suppl A): 101A.
4. Chatteje K. Dobutamine. a ten year review. New York: NCM publ, 1989.
5. McGillem MJ, De Boe SF, Friedmann HZ, Mancini GBJ. The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemia. Am Heart J 1988; 15: 970.